Abbott Laboratories Price Today

Abbott Laboratories
ABT
Healthcare
$161.13B
๐ฐ
Market Cap
31.7
๐ธ
Price to Earnings
$2.9
๐
EPS
+75
๐ณ
ESG
Consensus Recommendations
Buy Consensus
Buy |
13 |
Strong Buy |
8 |
Hold |
7 |
Sell |
0 |
Strong Sell |
0 |
ABT Price Forecast Target
92.8 ๐ 125.4 +35%
ABT EPS Forecast
2.9 ๐ 4.4 +49%
Financials
Profit Margin
13 %
Revenue Growth
-2.6 %
Dividend
$ 2.04
Held Percent
0.5% - Insiders
76.4% - Institutions
23.1% - Public
Major Fund Holders
-
๐ฐ Vanguard Group Inc $14.5B
-
๐ฐ Blackrock Inc. $12.7B
-
๐ฐ Capital Research Global Investors $7.2B
-
๐ฐ State Street Corporation $6.9B
-
๐ฐ Capital International Investors $5.5B
Stock Ideas
Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investmentโฆJim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, ChโฆJim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency tโฆNancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples aโฆ๐ฎFAQ
Some Frequently Asked Questions.

The Abbott Laboratories industry is Medical Devices

The Abbott Laboratories sector is Healthcare

The Abbott Laboratories forecasted predicted Price to Earnings PE ratio is 21.2

The Abbott Laboratories Price to Earnings PE ratio is 31.7

The Market Capitalization of Abbott Laboratories is $161.13B

There are total of 1722221320 float shares with 76.4% held by Institutions and 0.5% held by insiders

The MAbbott Laboratories forecasted Earnings per Share EPS is $4.4

The Abbott Laboratories Earnings per Share EPS is 2.9

The Abbott Laboratories company has $24579000000 gross profits with 13 profit margins

The Abbott Laboratories Earnings Growth is 0.012% with 0.001% quarterly earnings growth

The Abbott Laboratories Revenue is $39958999040 with -0.026 revenue growth

The price target for Abbott Laboratories stock is $125.4 for the high target and $94.3 for the low target

The consensus analyst recommendations for Abbott Laboratories is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.

The consensus analyst recommendations for Abbott Laboratories is Buy, with the following breakdown:
- Buy: 13
- Strong Buy: 8
- Hold: 7
- Sell: 0
- Strong Sell: 0

The Beta of Abbott Laboratories is 0.7

The dividend of Abbott Laboratories is $2.04

The dividend yield of Abbott Laboratories is 0.022%

The biggest institutional and mutual fund holders of Abbott Laboratories stock are
- Vanguard Group Inc
- Blackrock Inc.
- Capital Research Global Investors
- State Street Corporation

The Abbott Laboratories ESG Score is 75, with the following breakdown:
- E: 3.03
- S: 13.59
- G: 8.36